Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
NCT02237950
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
586
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Vaginosis
Interventions
DRUG:
Metronidazole oral tablets 500mg
DRUG:
1% SPL7013 Gel
DRUG:
Placebo gel
Sponsor
Starpharma Pty Ltd